查詢結果分析
來源資料
相關文獻
- Evaluation of Partial Splenic Embolization in Patients with Hypersplenism in Cirrhosis
- 肝硬化病人脾功能亢進症之治療:比較經導管脾動脈栓塞術與外科脾臟切除術之效果
- Portal Vein Thrombosis after Splenectomy in a Patient with Liver Cirrhosis and Esophageal Varices
- Pulmonary Function Changes in Cirrhotic Patients
- 肝硬化症併食道靜脈曲張施行短路手術時脾臟切除與否其血球和免疫球蛋白的研究
- 中醫治療肝纖維化的研究概況
- 肝硬化脾功能亢進治療之臨床角色
- 一位肝硬化合併脾腫大患者接受脾栓塞治療之護理經驗
- 脾膿瘍--左上腹痛的重要鑑別診斷
- Pancreatic Pseudocyst Involving the Spleen
頁籤選單縮合
題名 | Evaluation of Partial Splenic Embolization in Patients with Hypersplenism in Cirrhosis=部份脾栓塞術在肝硬化合併脾腫大症的評估 |
---|---|
作者 | 洪裕正; 胡華堃; 楊良友; 何子龍; 林瑞鵬; 林清澤; Hong, Yu-cheng; Wu, Hwa-koon; Yang, Albert D.; Ho, Tzu-lung; Lin, Anderson; Lin, Jackson CT; |
期刊 | 中華放射線醫學雜誌 |
出版日期 | 19991200 |
卷期 | 24:6 1999.12[民88.12] |
頁次 | 頁233-237 |
分類號 | 416.249 |
語文 | eng |
關鍵詞 | 脾; 治療性放射線術; 肝硬化; 動脈治療性阻塞; Spleen; Therapeutic radiology; Liver cirrhosis; Arteries therapeutic blockade; |
中文摘要 | 脾腫大症作脾切割術有一定程度的發病率和死亡率,我們應用部份脾栓塞術(PSE)治療肝硬化合併脾腫大症,作為一有效的治療方法來取代脾切割術。34例脾腫大合併血小板減少且經常出血的病人實施部份脾栓塞術。經由放在脾動脈的導管注入止血綿,直到血流減少至40-60且用術後血管攝影和電腦斷層檢查來評估脾梗塞程度。術後追蹤(平均10.93個月,範圍:1-48個月)顯示明顯且持久的血小板和白血球數目增加。13例脾腫大症復發,其脾梗塞程度常小於60。主要併發症為栓塞後症候群,但很少有生命危險。結論,在肝硬化合併脾腫大症,部份脾栓塞術為一有效且安全的治療方法。其結果和其它文獻報告類似。 |
英文摘要 | Where as splenectomy forhyperspicnism carries significantmorbidity and mortality rates, wehave used partial splenicembolization (PSE) as an effectivealternative to splenectomy in thetreatment of hypersplenism incirrhosis. Partial splenicembolization was performed in 34patients with hyperspicnism andthrombocytopenia associated withbleeding tendency. After selectivecatheterization of the splenicartery, partial splenic embolizationwas performed by means ofinjections of Gelfoam cubes until a40 to 60 reduction in the bloodflow was achieved . Splenicinfarction was assessed by post-embolization angiograms andcomputed tomography(CT). Afterpartial splenic embolization asignificant and sustained increasein platelet and white blood cellcounts was observed during thefollow up period (mean, 10.93mouths; range, I to 48 months).Hypersplenism recurred in 12patients, and most of themexhibited an embolization of lessthan 60 of the splenic mass. Post-embolization syndrome was themain side effect, but few life-threatening complications werefound. In conclusion, partialsplenic embolization is a safe andeffective therapy for hypersplenism in cirrhosis. The results arecomparable with other reports inthe reviewed active literature. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。